Mallcom (india) Share Price
Sector: Medical Equipment & Supplies
1326.00 +41.75 (3.25%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1284.00
Today’s High
1363.45
52 Week Low
1001.00
52 Week High
1780.00
1342.70 +57.90 (4.51%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1278.80
Today’s High
1352.00
52 Week Low
996.05
52 Week High
1785.00
Key Metrics
- Market Cap (In Cr) 831.03
- Beta 0.73
- Div. Yield (%) 0.23
- P/B 2.68
- TTM P/E 13.28
- Peg Ratio 0.67
- Sector P/E 0
- D/E 0
- Open Price 1299
- Prev Close 1284.25
Mallcom (india) Analysis
Price Analysis
-
1 Week2.52%
-
3 Months1.65%
-
6 Month-24.58%
-
YTD-15.63%
-
1 Year26.13%
Risk Meter
- 49% Low risk
- 49% Moderate risk
- 49% Balanced Risk
- 49% High risk
- 49% Extreme risk
Mallcom (india) News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
2 min read . 20 Dec 2024Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 18 Sep 2024Mallcom (india) Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 486.78
- Selling/ General/ Admin Expenses Total
- 19.9
- Depreciation/ Amortization
- 9.6
- Other Operating Expenses Total
- 9.18
- Total Operating Expense
- 435.51
- Operating Income
- 51.27
- Net Income Before Taxes
- 74.12
- Net Income
- 57.43
- Diluted Normalized EPS
- 60.5
- Period
- 2025
- Total Assets
- 492.77
- Total Liabilities
- 194.13
- Total Equity
- 298.64
- Tangible Book Valueper Share Common Eq
- 478.51
- Period
- 2025
- Cashfrom Operating Activities
- 1.7
- Cashfrom Investing Activities
- -43.11
- Cashfrom Financing Activities
- 15.18
- Net Changein Cash
- -26.22
- Period
- 2024
- Total Revenue
- 420.72
- Selling/ General/ Admin Expenses Total
- 43.12
- Depreciation/ Amortization
- 7.87
- Other Operating Expenses Total
- 2.86
- Total Operating Expense
- 370.9
- Operating Income
- 49.81
- Net Income Before Taxes
- 49.7
- Net Income
- 36.32
- Diluted Normalized EPS
- 58.15
- Period
- 2024
- Total Assets
- 387.72
- Total Liabilities
- 150.21
- Total Equity
- 237.51
- Tangible Book Valueper Share Common Eq
- 380.56
- Period
- 2024
- Cashfrom Operating Activities
- 6.37
- Cashfrom Investing Activities
- -9.78
- Cashfrom Financing Activities
- -4.17
- Net Changein Cash
- -7.57
- Period
- 2023
- Total Revenue
- 410.55
- Selling/ General/ Admin Expenses Total
- 38.09
- Depreciation/ Amortization
- 8.27
- Other Operating Expenses Total
- 2.61
- Total Operating Expense
- 360.34
- Operating Income
- 50.21
- Net Income Before Taxes
- 50.9
- Net Income
- 36.94
- Diluted Normalized EPS
- 59.13
- Period
- 2023
- Total Assets
- 354.23
- Total Liabilities
- 151
- Total Equity
- 203.23
- Tangible Book Valueper Share Common Eq
- 325.57
- Period
- 2023
- Cashfrom Operating Activities
- 53.45
- Cashfrom Investing Activities
- -75.04
- Cashfrom Financing Activities
- 33.03
- Net Changein Cash
- 11.44
- Period
- 2022
- Total Revenue
- 357.23
- Selling/ General/ Admin Expenses Total
- 25.73
- Depreciation/ Amortization
- 8.29
- Other Operating Expenses Total
- 2.53
- Total Operating Expense
- 315.83
- Operating Income
- 41.4
- Net Income Before Taxes
- 42.49
- Net Income
- 32.62
- Diluted Normalized EPS
- 51.23
- Period
- 2022
- Total Assets
- 279.11
- Total Liabilities
- 106.88
- Total Equity
- 172.23
- Tangible Book Valueper Share Common Eq
- 269.08
- Period
- 2022
- Cashfrom Operating Activities
- 1.25
- Cashfrom Investing Activities
- -1.96
- Cashfrom Financing Activities
- -1.41
- Net Changein Cash
- -2.12
- Period
- 2021
- Total Revenue
- 316.88
- Selling/ General/ Admin Expenses Total
- 21.9
- Depreciation/ Amortization
- 5.78
- Other Operating Expenses Total
- 2.21
- Total Operating Expense
- 281.05
- Operating Income
- 35.83
- Net Income Before Taxes
- 37.45
- Net Income
- 28.27
- Diluted Normalized EPS
- 45.28
- Period
- 2021
- Total Assets
- 252.54
- Total Liabilities
- 111.05
- Total Equity
- 141.49
- Tangible Book Valueper Share Common Eq
- 219.6
- Period
- 2021
- Cashfrom Operating Activities
- 18.82
- Cashfrom Investing Activities
- -11.56
- Cashfrom Financing Activities
- 18.1
- Net Changein Cash
- 25.37
- Period
- 2020
- Total Revenue
- 287.69
- Selling/ General/ Admin Expenses Total
- 22.81
- Depreciation/ Amortization
- 5.63
- Other Operating Expenses Total
- 1.84
- Total Operating Expense
- 260.28
- Operating Income
- 27.41
- Net Income Before Taxes
- 25.3
- Net Income
- 18.88
- Diluted Normalized EPS
- 28.44
- Period
- 2020
- Total Assets
- 196.87
- Total Liabilities
- 86.67
- Total Equity
- 110.2
- Tangible Book Valueper Share Common Eq
- 176.12
- Period
- 2020
- Cashfrom Operating Activities
- 37.68
- Cashfrom Investing Activities
- -21.35
- Cashfrom Financing Activities
- -14
- Net Changein Cash
- 2.33
- Period
- 2019
- Total Revenue
- 300.79
- Selling/ General/ Admin Expenses Total
- 27.67
- Depreciation/ Amortization
- 5.65
- Other Operating Expenses Total
- 1.41
- Total Operating Expense
- 274.33
- Operating Income
- 26.46
- Net Income Before Taxes
- 22.69
- Net Income
- 14.99
- Diluted Normalized EPS
- 24.02
- Period
- 2019
- Total Assets
- 198.71
- Total Liabilities
- 105.49
- Total Equity
- 93.21
- Tangible Book Valueper Share Common Eq
- 147.89
- Period
- 2019
- Cashfrom Operating Activities
- 21.35
- Cashfrom Investing Activities
- -13.68
- Cashfrom Financing Activities
- -6.66
- Net Changein Cash
- 1.01
- Period
- 2025-03-31
- Total Revenue
- 137.57
- Selling/ General/ Admin Expenses Total
- 5.86
- Depreciation/ Amortization
- 2.68
- Other Operating Expenses Total
- 3.79
- Total Operating Expense
- 124.86
- Operating Income
- 12.72
- Net Income Before Taxes
- 35.85
- Net Income
- 29.77
- Diluted Normalized EPS
- 13.91
- Period
- 2025-03-31
- Total Assets
- 492.77
- Total Liabilities
- 194.13
- Total Equity
- 298.64
- Tangible Book Valueper Share Common Eq
- 478.51
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 1.7
- Cashfrom Investing Activities
- -43.11
- Cashfrom Financing Activities
- 15.18
- Net Changein Cash
- -26.22
- Period
- 2024-12-31
- Total Revenue
- 117.74
- Selling/ General/ Admin Expenses Total
- 4.94
- Depreciation/ Amortization
- 2.5
- Other Operating Expenses Total
- 1.08
- Total Operating Expense
- 104.93
- Operating Income
- 12.8
- Net Income Before Taxes
- 12.24
- Net Income
- 9.03
- Diluted Normalized EPS
- 14.46
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 129.08
- Selling/ General/ Admin Expenses Total
- 4.64
- Depreciation/ Amortization
- 2.31
- Other Operating Expenses Total
- 1.6
- Total Operating Expense
- 115.56
- Operating Income
- 13.52
- Net Income Before Taxes
- 14.54
- Net Income
- 10.1
- Diluted Normalized EPS
- 16.19
- Period
- 2024-09-30
- Total Assets
- 437.43
- Total Liabilities
- 182.57
- Total Equity
- 254.86
- Tangible Book Valueper Share Common Eq
- 408.38
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 0.43
- Cashfrom Investing Activities
- -7.83
- Cashfrom Financing Activities
- 2.89
- Net Changein Cash
- -4.51
- Period
- 2024-06-30
- Total Revenue
- 102.38
- Selling/ General/ Admin Expenses Total
- 5.05
- Depreciation/ Amortization
- 2.1
- Other Operating Expenses Total
- 2.72
- Total Operating Expense
- 90.16
- Operating Income
- 12.23
- Net Income Before Taxes
- 11.5
- Net Income
- 8.53
- Diluted Normalized EPS
- 13.67
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 122.36
- Selling/ General/ Admin Expenses Total
- 5.44
- Other Operating Expenses Total
- 2.83
- Total Operating Expense
- 105.08
- Operating Income
- 17.28
- Net Income Before Taxes
- 16.97
- Net Income
- 11.81
- Diluted Normalized EPS
- 18.92
- Period
- 2024-03-31
- Total Assets
- 387.72
- Total Liabilities
- 150.21
- Total Equity
- 237.51
- Tangible Book Valueper Share Common Eq
- 380.56
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 6.37
- Cashfrom Investing Activities
- -9.78
- Cashfrom Financing Activities
- -4.17
- Net Changein Cash
- -7.57
- Period
- 2023-12-31
- Total Revenue
- 95.56
- Selling/ General/ Admin Expenses Total
- 4.47
- Depreciation/ Amortization
- 3.28
- Other Operating Expenses Total
- 1.11
- Total Operating Expense
- 87.2
- Operating Income
- 8.36
- Net Income Before Taxes
- 8.77
- Net Income
- 6.83
- Diluted Normalized EPS
- 10.95
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Mallcom (india) Technical
Moving Average
SMA
- 5 Day1292.51
- 10 Day1229.57
- 20 Day1170.74
- 50 Day1180.08
- 100 Day1207.81
- 300 Day1356.81
Mallcom (india) Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Poly Medicure
- 2160.65
- -30.3
- -1.38
- 3350
- 1788.05
- 21940.95
- Mallcom (india)
- 1326
- 41.75
- 3.25
- 1780
- 1001
- 831.03
- Prevest Denpro
- 477.85
- 0.7
- 0.15
- 686
- 393.6
- 573.74
- Nureca
- 282.25
- 1.6
- 0.57
- 447
- 198
- 282.25
- One Global Service Provider
- 230.3
- 4.5
- 1.99
- 407.6
- 122.8
- 163.62
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Poly Medicure
- 64.29
- 8.03
- 16.63
- 18.03
- Mallcom (india)
- 21.48
- 2.72
- 19.98
- 9.57
- Prevest Denpro
- 31.09
- 5.35
- 22.1
- 29.75
- Nureca
- 342.78
- 1.45
- 9.56
- 10.5
- One Global Service Provider
- 23.75
- 6.03
- 43.59
- 12.75
Mallcom (india) Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 19-May-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results & Others
- 12-Nov-24
- Quarterly Results
- 26-Jul-24
- Quarterly Results
- 28-May-24
- Audited Results & Final Dividend
- 12-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 29-May-23
- Audited Results & Final Dividend
- 08-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 19-Sept-24
- 02-Sept-24
- AGM
- 23-Jan-24
- 21-Dec-23
- POM
- 11-Sept-23
- 17-Aug-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 19-May-25
- -
- -
- 3
- 28-May-24
- -
- 12-Sept-24
- 3
- 29-May-23
- -
- 04-Sept-23
- 3
- 31-May-22
- -
- 09-Sept-22
- 3
- 21-Jun-21
- -
- 01-Sept-21
- 3


